上颌骨混合性上皮–结缔组织型磷酸盐尿性间叶性肿瘤1例
A Case of Mixed Epithelial-Connective Tissue Type Phosphaturic Mesenchymal Tumor of the Maxilla
DOI: 10.12677/ACM.2022.12111522, PDF,    科研立项经费支持
作者: 洪嘉韫:西安医学院,陕西 西安;王 萍, 雷建园, 李文生*:陕西省人民医院病理科,陕西 西安;张国平:陕西省人民医院影像科,陕西 西安
关键词: 磷酸盐尿性间叶性肿瘤上颌骨Phosphate Urinary Mesenchymal Tumor Maxilla
摘要: 目的:报道1例上颌骨混合性上皮–结缔组织型磷酸盐尿性间叶性肿瘤(PMTMECT)患者的临床病理特征、治疗及预后。方法:回顾性分析1例PMTMECT患者的临床表现、病理特征、治疗及预后,并进行文献复习。结果:31岁男性患者,双侧髋关节疼痛加重伴腰背部疼痛入院。组织学形态结果显示:肿瘤组织由上皮和间叶两种成分组成,间叶成分由梭形细胞构成,肿瘤细胞呈血管外皮瘤样排列,可见“污浊”或絮状钙化基质。上皮成分类似牙源性上皮,以片状或不规则巢状广泛分布在肿瘤间。免疫组化染色显示肿瘤细胞表达间叶标志物Vimentin、上皮标志物AE1/AE3、Ki-67指数约5%。病理诊断为PMTMECT后,患者经手术切除治疗,目前随访2年,病情未复发。结论:PMTMECT肿瘤体积一般较小,临床无特异性表现,易漏诊,手术切除效果好。
Abstract: Objective: To report the clinicopathological features, treatment and prognosis of a patient with mixed epithelial-connective tissue-type phosphaturic mesenchymal tumor of the maxilla (PMTMECT). Methods: The clinical presentation, pathological features, treatment and prognosis of a patient with PMTMECT were retrospectively analyzed, and the literature was reviewed. Results: A 31-year-old male patient with increased bilateral hip pain with low back pain was admitted to the hospital. The histological findings showed that the tumor tissue consisted of both epithelial and mesenchymal components, with the mesenchymal component consisting of spindle-shaped cells, and the tumor cells were arranged in a hemangiopericytoma-like pattern, with a “stained” or floc-culent calcified stroma. The epithelial component resembled odontogenic epithelium and was widely distributed among the tumors in sheets or irregular nests. Immunohistochemical staining showed that the index of tumor cells expressed mesenchymal marker Vimentin, epithelial marker AE1/AE3, and Ki-67 is about 5%. After pathological diagnosis of PMTMECT, the patient was treated with surgical resection and is currently followed up for 2 years with no recurrence of disease. Con-clusion: PMTMECT tumors are generally small in size, have no specific clinical manifestations, are easily missed, and have good surgical resection results.
文章引用:洪嘉韫, 王萍, 雷建园, 张国平, 李文生. 上颌骨混合性上皮–结缔组织型磷酸盐尿性间叶性肿瘤1例[J]. 临床医学进展, 2022, 12(11): 10573-10578. https://doi.org/10.12677/ACM.2022.12111522

参考文献

[1] Weidner, N. and Santa C.D. (1987) Phosphaturic Mesenchymal Tumors. A Polymorphous Group Causing Osteomalacia or Rickets. Cancer, 59, 1442-1454. [Google Scholar] [CrossRef
[2] Wu, H.W., Bui, M.M. et al. (2019) Phosphaturic Mesenchymal Tumor with an Admixture of Epithelial and Mesenchymal Elements in the Jaws: Clinicopathological and Immunohistochemical Analysis of 22 Cases with Literature Review. Modern Pa-thology, 32, 189-204. [Google Scholar] [CrossRef] [PubMed]
[3] Folpe, A.L. (2019) Phosphaturic Mesen-chymal Tumors: A Review and Update. Seminars in Diagnostic Pathology, 36, 260-268. [Google Scholar] [CrossRef] [PubMed]
[4] Tenenhouse, H.S. (2007) Phosphate Transport: Molecular Basis, Regulation and Pathophysiology. The Journal of Steroid Biochemistry and Molecular Biology, 103, 572-577. [Google Scholar] [CrossRef] [PubMed]
[5] Shimada, T., Mizutani, S., Muto, T., Yoneya, T., et al. (2001) Cloning and Characterization of FGF23 as a Causative Factor of Tumor-Induced Osteomalacia. Proceedings of the Na-tional Academy of Sciences, 98, 6500-6505. [Google Scholar] [CrossRef] [PubMed]
[6] Dutta, D., Pandey, R.K., Gogoi, R., et al. (2018) Occult Phosphaturic Mesenchymal Tumour of Femur Cortex Causing Oncogenic Osteomalacia—Diagnostic Challenges and Clinical Out-comes. Endokrynologia Polska, 69, 205-210.
[7] 单凤玲, 孙贞魁, 沈晨天, 等. 磷酸盐尿性间叶肿瘤的临床特点及其综合影像学表现[J]. 国际放射医学核医学杂志, 2021, 45(8): 479-485.
[8] Breer, S., Brunkhorst, T., Beil, F.T., et al. (2014) 68Ga DOTA-TATE PET/CT Allows Tumor Localization in Patients with Tumor-Induced Osteomalacia But Negative 111In-Octreotide SPECT/CT. Bone, 64, 222-227. [Google Scholar] [CrossRef] [PubMed]
[9] Weidner, N. (1991) Review and Update: Oncogenic Osteomala-cia-Rickets. Ultrastructural Pathology, 15, 317-333. [Google Scholar] [CrossRef] [PubMed]
[10] 张欣, 钟定荣, 邢荣格. 磷酸盐尿性间叶肿瘤12例临床病理分析[J]. 临床与实验病理学杂志, 2015, 31(4): 426-430.
[11] Yamada, Y., Kinoshita, I., Kenichi, K., et al. (2018) Histopathological and Genetic Review of Phosphaturic Mesenchymal Tumours, Mixed Connective Tissue Variant. His-topathology, 72, 460-471. [Google Scholar] [CrossRef] [PubMed]
[12] Tajima, S. and Fukayama, M. (2015) CD56 May Be a More Useful Immunohistochemical Marker than Somatostatin Receptor 2A for the Diagnosis of Phosphaturic Mesenchymal Tumors. International Journal of Clinical and Experimental Pathology, 8, 8159-8164.
[13] 宋春红, 吴亮, 殷薇薇, 等. 3例不同部位磷酸盐尿性间叶性肿瘤临床病理特征分析[J]. 温州医科大学学报, 2022(2): 153-157.
[14] Agaimy, A., Michal, M., Chiosea, S., et al. (2017) Phosphaturic Mesenchymal Tumors: Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic Spec-trum. The American Journal of Surgical Pathology, 41, 1371-1380. [Google Scholar] [CrossRef